Amedisys/ US0234361089 /
| 2024-04-25 9:59:55 PM | Chg. +0.13 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 91.20USD | +0.14% | 10,896 Turnover: 993,148.60 |
-Bid Size: - | -Ask Size: - | 2.98 bill.USD | - | - |
Assets
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 29.4490 | 28.1000 | 23.7000 | 18.4000 | 16 | ||||||
| Intangible Assets | 44.1320 | 64.7000 | 74.2000 | 111.2000 | 101.2000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 493 | 912.1910 | 1,205.2140 | 1,500.2840 | 1,587.2840 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 188.9720 | 237.5960 | 255.1450 | 274.9610 | 296.7850 | ||||||
| Cash and Cash Equivalents | 20.2290 | 30.3000 | 81.8000 | 42.7000 | 40.5000 | ||||||
| Current Assets | 224.1180 | 350.5540 | 361.9840 | 356.6840 | 388.9610 | ||||||
| Total Assets | 717.1180 | 1,262.7450 | 1,567.1980 | 1,856.9680 | 1,976.2450 | ||||||
Liabilities
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 28.5310 | 31.2590 | 42.6740 | 38.2170 | 43.7350 | ||||||
| Long-term debt | 5.7750 | 232.3000 | 204.5000 | 432.0750 | 419.4200 | ||||||
| Liabilities to Banks | 5.8000 | 232.3000 | - | - | - | ||||||
| Provisions | 1.6000 | 37.7000 | - | - | - | ||||||
| Liabilities | 234.4850 | 621.2320 | 756.4570 | 880.6450 | 869.6720 | ||||||
| Share Capital | .0360 | .0370 | .0380 | .0380 | .0380 | ||||||
| Total Equity | 482.6330 | 641.5130 | 810.7410 | 976.3230 | 1,106.5730 | ||||||
| Minority Interests | 1.0510 | 1.0630 | 1.5170 | 44.9720 | 55 | ||||||
| Total liabilities equity | 717.1180 | 1,262.7450 | 1,567.1980 | 1,856.9680 | 1,976.2450 | ||||||
Income Statement
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,662.5780 | 1,955.6000 | 2,071.5000 | 2,214.1000 | 2,223.2000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 155.1000 | 177.5000 | 219.3000 | 251.9000 | 180.8000 | ||||||
| Interest Income | -7.0920 | -14.4370 | -10.7460 | -9.4760 | -22.0500 | ||||||
| Income Before Taxes | 158.9880 | 170.4100 | 210.8190 | 280.2310 | 160.2440 | ||||||
| Income Taxes | -38.8590 | -42.5000 | -25.6000 | -70.1000 | -42.5000 | ||||||
| Minority Interests Profit | -.7830 | -1.0740 | -1.5760 | -1.0940 | .9100 | ||||||
| Net Income | 119.3460 | 126.8000 | 183.6000 | 209.0720 | 118.6090 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 223.4830 | 202 | 288.9520 | 188.8930 | 133.2830 | ||||||
| Cash Flow from Investing Activities | -22.1930 | -352.9480 | -287.1080 | -281.6070 | -94.4860 | ||||||
| Cash Flow from Financing | -267.4240 | 227.2090 | -14.9770 | 55.1260 | -30.4330 | ||||||
| Decrease / Increase in Cash | -66.1340 | 76.2610 | -13.1330 | -37.5880 | 8.3640 | ||||||
| Employees | 21,000 | 21,300 | - | - | - | ||||||
